BioVie Stock (NASDAQ: BIVI) stock price, news, charts, stock research, profile.
Open | $0.44 |
Close | $0.40 |
Volume / Avg. | 1.37M / 627.35K |
Day Range | 0.40 - 0.44 |
52 Wk Range | 0.41 - 5.82 |
Market Cap | $26.79M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 3.04% |
Days to Cover | 2.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.
Other companies in BioVie’s space includes: NKGen Biotech (NASDAQ:NKGN), Gain Therapeutics (NASDAQ:GANX), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
There is no analysis for BioVie.
BioVie has a consensus price target of $12.75.
The stock price for BioVie (NASDAQ: BIVI) is $0.438 last updated June 28, 2024 at 7:20 PM EDT.
There are no upcoming dividends for BioVie.
BioVie’s Q4 earnings are confirmed for Wednesday, August 14, 2024.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.